# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
1 | 05-14-2024 | 03-31-2024 | 10-Q | |
2 | 02-29-2024 | 12-31-2023 | 10-K |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Company Holds 150+ Patents For Fibroblast-Based Therapeutics And Cures For Chronic Diseases
- SEC Filing